Mycosis Fungoides

• FDA approval · 2013-04-24
  FDA Approved: ZOLINZA — Supplemental Application (Merck Sharp & Dohme LLC)

  The FDA approved a supplemental application for Zolinza (vorinostat) filed by Merck. The action updates the labeling and may reflect changes…

• FDA approval · 2009-11-05
  FDA Approved: ISTODAX — Original Application (Celgene Corporation)

  The FDA granted original approval for ISTODAX (romidepsin) to Celgene. The approval covered treatment for cutaneous T-cell lymphoma, includi…

• FDA approval · 2006-10-06
  FDA Approved: ZOLINZA — Original Application (Merck Sharp & Dohme LLC)

  The FDA approved Zolinza (vorinostat) under original NDA for cutaneous T-cell lymphoma, marking the first approval of this histone deacetyla…